 | • レポートコード：MRC2211A008 • 出版社/出版日：Persistence Market Research / 2022年9月 • レポート形態：英文、PDF、250ページ • 納品方法：Eメール • 産業分類：バイオ |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Site Licence | ￥1,124,800 (USD7,600) | ▷ お問い合わせ |
| Enterprisewide | ￥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Persistence Market Research社の本調査レポートは、生体材料の世界市場について調査し、エグゼクティブサマリー、市場概要、主要市場動向、主要成功要因、新型コロナウイルス感染症の危機分析、市場背景、需要分析・予測、材料別（金属生体材料、セラミック生体材料、高分子生体材料、天然生体材料）分析、用途別（歯科、循環器、整形外科、創傷治癒、神経）分析、地域別（北米、中南米、ヨーロッパ、東アジア、南アジア、オセアニア、中東/アフリカ）分析、仮定、調査手法などを整理しております。本書では、Evonik Industries AG、Medtronic plc、Carpenter Technology Corporation、Invibio Ltd.、Berkeley Advanced Biomaterials、BASF SE、Zimmer Biomet Holdings, Inc.、Stryker、Covalon Technologies Ltd.、Johnson＆Johnsonなどの企業情報が含まれています。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・主要成功要因 ・新型コロナウイルス感染症の危機分析 ・市場背景 ・需要分析・予測 ・世界の生体材料市場規模：材料別 - 金属生体材料の市場規模 - セラミック生体材料の市場規模 - 高分子生体材料の市場規模 - 天然生体材料の市場規模 ・世界の生体材料市場規模：用途別 - 歯科における市場規模 - 循環器における市場規模 - 整形外科における市場規模 - 創傷治癒における市場規模 - 神経における市場規模 ・世界の生体材料市場規模：地域別 - 北米の生体材料市場規模 - 中南米の生体材料市場規模 - ヨーロッパの生体材料市場規模 - 東アジアの生体材料市場規模 - 南アジアの生体材料市場規模 - オセアニアの生体材料市場規模 - 中東/アフリカの生体材料市場規模 ・仮定 ・調査手法 |
Biomaterials Market: Report Scope
The latest market report by Persistence Market Research on the global biomaterials market evaluates the opportunities and current market scenario, providing insights and updates about corresponding segments involved in the market for the forecast period of 2022-2032. The report provides detailed assessment of key market dynamics, and comprehensive information about the structure of the market. This study contains detailed insights into how the market is anticipated to grow during the forecast period of 2022-2032.
The primary objective of the report is to provide insights regarding opportunities in the market that are supporting the transformation of global businesses associated with Biomaterials. It is very important to consider that, in an ever-wavering economy, we provide estimated (Y-o-Y) year-on-year growth rate in addition to compound annual growth rate (CAGR) for overall forecasts, to enable readers better understand the analysis and evaluation of the market, and to discover lucrative opportunities in this space.
This report also provides an estimate of market size and corresponding revenue forecasts carried out in terms of absolute $ opportunity. It also offers actionable insights based on the future trends in the market. Furthermore, new and emerging players in the global biomaterials market can make use of the information presented in the study for effective business decisions, which will provide momentum to their businesses as well as the global market.
The study is relevant for manufacturers, suppliers, distributors, and investors in the biomaterials market. All stakeholders, as well as industry experts, researchers, journalists, and business researchers can leverage the information and data represented in the report.
Key Market Segments
Persistence Market Research’s report on the global biomaterials market offers information divided into four segments – material, application, and region.
Material
Metallic Biomaterials
Ceramic Biomaterials
Polymeric Biomaterials
Natural Biomaterials
Application
Dental
Cardiovascular
Orthopedic
Wound Healing
Neurology
Surgery
Region
North America
Latin America
Europe
South Asia and Pacific
East Asia
Middle East and Africa
Key Questions Answered in Study
Which region will hold the highest market share over the forecast period?
Which region is experiencing the highest growth (CAGR)?
Which factors are impacting the global biomaterials industry?
What are the global trends impacting the market?
What strategies must emerge players adopt to capture opportunities in various regions in the market?
What is the structure of the global biomaterials market?
Research Methodology
Persistence Market Research is committed to providing unbiased market research solutions to its clients. The company follows a robust methodology for the deduction of data included in this report. A unique research methodology is utilized to conduct extensive research on the global biomaterials market, and reach conclusions about the future growth factors of the market. The research methodology comprises primary research methods coupled with secondary research methods, which ensures the accuracy and reliability of the conclusions in this report.
A demand-side approach is followed to estimate the sales of target products, followed by an in-depth supply-side assessment of value generated, key trends, and events over a predefined period.
This methodology is based on standard market structures, methods, and definitions that are based on inputs from local sources in over six regions – North America, Latin America, Europe, South Asia and Pacific, East Asia, and the Middle East & Africa, which Persistence Market Research considers for segmenting the global market. Statistics, characteristics, and variances are collected at a regional level, aggregated at the same level, and then synthesized at a worldwide level, to create global market measurements.
Our main sources of research include:
Primary Research
Secondary Research
Trade Research
Social Media Research
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Innovation / Development Trends
4. Key Success Factors
4.1. Product Adoption Analysis
4.2. Obesity Rate by Country
4.3. Obesity Drugs Pipeline Analysis
4.4. Obesity Drug Withdrawal Analysis
4.5. Obesity Drug / Device Withdrawal, Termination from Clinical Trials
4.6. Regulatory Scenario
4.7. Key Promotional Strategies by Manufacturers
4.8. Porter’s Analysis
4.9. PESTEL Analysis
5. COVID19 Crisis Analysis
5.1. Current COVID19 Statistics and Probable Future Impact
5.2. Current GDP Projection and Probable Impact
5.3. Current Economic Projection as compared to 2008 Economic analysis
5.4. COVID-19 and Impact Analysis
5.4.1. Revenue by Material
5.4.2. Revenue by Application
5.4.3. Revenue by Country
6. Market Background
6.1. Macro-Economic Factors
6.1.1. Global GDP Growth Outlook
6.1.2. Per-Capita Healthcare Expenditure
6.2. Forecast Factors – Relevance & Impact
6.2.1. COVID-19 Pandemic
6.2.2. Rise in R&D Investments
6.2.3. Top Biomaterial Companies and Their Historical Growth
6.2.4. Rise in Number of Clinical Studies
6.2.5. GDP Growth
6.2.6. Adoption Rate of Biomaterial Products
6.3. Market Dynamics
6.3.1. Drivers
6.3.2. Restraints
6.3.3. Opportunity Analysis
7. Global Biomaterials Market Demand (in Value or Size in US$ MN) Analysis 2017–2021 and Forecast, 2022–2032
7.1. Historical Market Value (US$ MN) Analysis, 2017–2021
7.2. Current and Future Market Value (US$ MN) Projections, 2022–2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Biomaterials Market Analysis 2017–2021 and Forecast 2022–2032, by Material
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis by Material, 2017 – 2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Material, 2022 – 2032
8.3.1. Metallic Biomaterials
8.3.2. Ceramic Biomaterials
8.3.3. Polymeric Biomaterials
8.3.4. Natural Biomaterials
8.4. Market Attractiveness Analysis by Material
9. Global Biomaterials Market Analysis 2017–2021 and Forecast 2022–2032, by Application
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis by Application, 2017 – 2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Application, 2022- 2032
9.3.1. Dental
9.3.2. Cardiovascular
9.3.3. Orthopedic
9.3.4. Wound Healing
9.3.5. Neurology
9.3.6. Surgery
9.4. Market Attractiveness Analysis by Application
10. Global Biomaterials Market Analysis 2017–2021 and Forecast 2022–2032, by Region
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis by Region, 2017 – 2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Region, 2022- 2032
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. East Asia
10.3.5. South Asia
10.3.6. Oceania
10.3.7. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region
11. North America Biomaterials Market Analysis 2017–2021 and Forecast 2022–2032
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2017 – 2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2022- 2032
11.3.1. By Country
11.3.1.1. U.S.
11.3.1.2. Canada
11.3.2. By Material
11.3.3. By Application
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Material
11.4.3. By Application
11.5. Market Trends
11.6. Key Market Participants – Intensity Mapping
11.7. Drivers and Restraints – Impact Analysis
11.8. Country Level Analysis & Forecast
11.8.1. U.S. Biomaterials Market Analysis
11.8.1.1. Introduction
11.8.1.2. Market Analysis and Forecast by Market Taxonomy
11.8.1.2.1. By Material
11.8.1.2.2. By Application
11.8.2. Canada Biomaterials Market Analysis
11.8.2.1. Introduction
11.8.2.2. Market Analysis and Forecast by Market Taxonomy
11.8.2.2.1. By Material
11.8.2.2.2. By Application
12. Latin America Biomaterials Market Analysis 2017–2021 and Forecast 2022–2032
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2017 – 2021
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2022- 2032
12.3.1. By Country
12.3.1.1. Mexico
12.3.1.2. Brazil
12.3.1.3. Argentina
12.3.1.4. Rest of Latin America
12.3.1.4.1. By Material
12.3.1.4.2. By Application
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Material
12.4.3. By Application
12.5. Market Trends
12.6. Key Market Participants – Intensity Mapping
12.7. Drivers and Restraints – Impact Analysis
12.8. Country Level Analysis & Forecast
12.8.1. Mexico Biomaterials Market Analysis
12.8.1.1. Introduction
12.8.1.2. Market Analysis and Forecast by Market Taxonomy
12.8.1.2.1. By Material
12.8.1.2.2. By Application
12.8.2. Brazil Biomaterials Market Analysis
12.8.2.1. Introduction
12.8.2.2. Market Analysis and Forecast by Market Taxonomy
12.8.2.2.1. By Material
12.8.2.2.2. By Application
12.8.3. Argentina Biomaterials Market Analysis
12.8.3.1. Introduction
12.8.3.2. Market Analysis and Forecast by Market Taxonomy
12.8.3.2.1. By Material
12.8.3.2.2. By Application
13. Europe Biomaterials Market Analysis 2017–2021 and Forecast 2022–2032
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2017 – 2021
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2022- 2032
13.3.1. By Country
13.3.1.1. Germany
13.3.1.2. Italy
13.3.1.3. France
13.3.1.4. U.K.
13.3.1.5. Spain
13.3.1.6. BENELUX
13.3.1.7. Nordic Countries & Russia
13.3.1.8. Rest of Europe
13.3.2. By Material
13.3.3. By Application
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Material
13.4.3. By Application
13.5. Market Trends
13.6. Key Market Participants – Intensity Mapping
13.7. Drivers and Restraints – Impact Analysis
13.8. Country Level Analysis & Forecast
13.8.1. Germany Biomaterials Market Analysis
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast by Market Taxonomy
13.8.1.2.1. By Material
13.8.1.2.2. By Application
13.8.2. Italy Biomaterials Market Analysis
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast by Market Taxonomy
13.8.2.2.1. By Material
13.8.2.2.2. By Application
13.8.3. France Biomaterials Market Analysis
13.8.3.1. Introduction
13.8.3.2. Market Analysis and Forecast by Market Taxonomy
13.8.3.2.1. By Material
13.8.3.2.2. By Application
13.8.4. U.K. Biomaterials Market Analysis
13.8.4.1. Introduction
13.8.4.2. Market Analysis and Forecast by Market Taxonomy
13.8.4.2.1. By Material
13.8.4.2.2. By Application
13.8.5. Spain Biomaterials Market Analysis
13.8.5.1. Introduction
13.8.5.2. Market Analysis and Forecast by Market Taxonomy
13.8.5.2.1. By Material
13.8.5.2.2. By Application
13.8.6. BENELUX Biomaterials Market Analysis
13.8.6.1. Introduction
13.8.6.2. Market Analysis and Forecast by Market Taxonomy
13.8.6.2.1. By Material
13.8.6.2.2. By Application
13.8.7. Nordic Countries & Russia Biomaterials Market Analysis
13.8.7.1. Introduction
13.8.7.2. Market Analysis and Forecast by Market Taxonomy
13.8.7.2.1. By Material
13.8.7.2.2. By Application
14. East Asia Biomaterials Market Analysis 2017–2021 and Forecast 2022–2032
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2017 – 2021
14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2022- 2032
14.3.1. By Country
14.3.1.1. China
14.3.1.2. Japan
14.3.1.3. South Korea
14.3.1.3.1. By Material
14.3.1.3.2. By Application
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Material
14.4.3. By Application
14.5. Market Trends
14.6. Key Market Participants – Intensity Mapping
14.7. Drivers and Restraints – Impact Analysis
14.8. Country Level Analysis & Forecast
14.8.1. China Biomaterials Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Material
14.8.1.2.2. By Application
14.8.2. Japan Biomaterials Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Material
14.8.2.2.2. By Application
14.8.3. South Korea Biomaterials Market Analysis
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast by Market Taxonomy
14.8.3.2.1. By Material
14.8.3.2.2. By Application
15. South Asia Biomaterials Market Analysis 2017–2021 and Forecast 2022–2032
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2017 – 2021
15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2022- 2032
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Indonesia
15.3.1.3. Malaysia
15.3.1.4. Philippines
15.3.1.5. Thailand
15.3.1.6. Vietnam
15.3.1.7. Rest of South Asia
15.3.2. By Material
15.3.3. By Application
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Material
15.4.3. By Application
15.5. Market Trends
15.6. Key Market Participants – Intensity Mapping
15.7. Drivers and Restraints – Impact Analysis
15.8. Country Level Analysis & Forecast
15.8.1. India Biomaterials Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Material
15.8.1.2.2. By Application
15.8.2. Indonesia Biomaterials Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Material
15.8.2.2.2. By Application
15.8.3. Malaysia Biomaterials Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Material
15.8.3.2.2. By Application
15.8.4. Philippines Biomaterials Market Analysis
15.8.4.1. Introduction
15.8.4.2. Market Analysis and Forecast by Market Taxonomy
15.8.4.2.1. By Material
15.8.4.2.2. By Application
15.8.5. Thailand Biomaterials Market Analysis
15.8.5.1. Introduction
15.8.5.2. Market Analysis and Forecast by Market Taxonomy
15.8.5.2.1. By Material
15.8.5.2.2. By Application
15.8.6. Vietnam Biomaterials Market Analysis
15.8.6.1. Introduction
15.8.6.2. Market Analysis and Forecast by Market Taxonomy
15.8.6.2.1. By Material
15.8.6.2.2. By Application
16. Oceania Biomaterials Market 2017-2021 and Forecast 2022-2032
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2017 – 2021
16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2022- 2032
16.3.1. By Country
16.3.1.1. Australia
16.3.1.2. New Zealand
16.3.2. By Material
16.3.3. By Application
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Material
16.4.3. By Application
16.5. Market Trends
16.6. Key Market Participants – Intensity Mapping
16.7. Drivers and Restraints – Impact Analysis
16.8. Country Level Analysis & Forecast
16.8.1. Australia Biomaterials Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Material
16.8.1.2.2. By Application
16.8.2. New Zealand Biomaterials Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Material
16.8.2.2.2. By Application
17. Middle East and Africa (MEA) Biomaterials Market Analysis 2017–2021 and Forecast 2022–2032
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2017 – 2021
17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2022- 2032
17.3.1. By Country
17.3.1.1. GCC Countries
17.3.1.2. Israel
17.3.1.3. Turkey
17.3.1.4. South Africa & North Africa
17.3.1.5. Rest of Middle East and Africa
17.3.2. By Material
17.3.3. By Application
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Material
17.4.3. By Application
17.5. Market Trends
17.6. Key Market Participants – Intensity Mapping
17.7. Drivers and Restraints – Impact Analysis
17.8. Country Level Analysis & Forecast
17.8.1. GCC Countries Biomaterials Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Material
17.8.1.2.2. By Application
17.8.2. Israel Biomaterials Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Material
17.8.2.2.2. By Application
17.8.3. Turkey Biomaterials Market Analysis
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Material
17.8.3.2.2. By Application
17.8.4. South Africa & North Africa Biomaterials Market Analysis
17.8.4.1. Introduction
17.8.4.2. Market Analysis and Forecast by Market Taxonomy
17.8.4.2.1. By Material
17.8.4.2.2. By Application
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies
18.2. Market Share Analysis of Top Players
18.3. Market Presence Analysis
18.3.1. Regional footprint of Players
18.3.2. Channel Foot Print by Players
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive
19.3.1. Evonik Industries AG
19.3.1.1. Overview
19.3.1.2. Product Portfolio
19.3.1.3. Key Financials by Market Segments (Product/Channel/Region)
19.3.1.4. Sales Footprint
19.3.1.5. Strategy Overview
19.3.1.6. SWOT Analysis
19.3.2. Medtronic plc
19.3.2.1. Overview
19.3.2.2. Product Portfolio
19.3.2.3. Key Financials by Market Segments (Product/Channel/Region)
19.3.2.4. Sales Footprint
19.3.2.5. Strategy Overview
19.3.2.6. SWOT Analysis
19.3.3. Carpenter Technology Corporation
19.3.3.1. Overview
19.3.3.2. Product Portfolio
19.3.3.3. Key Financials by Market Segments (Product/Channel/Region)
19.3.3.4. Sales Footprint
19.3.3.5. Strategy Overview
19.3.3.6. SWOT Analysis
19.3.4. Invibio Ltd.
19.3.4.1. Overview
19.3.4.2. Product Portfolio
19.3.4.3. Key Financials by Market Segments (Product/Channel/Region)
19.3.4.4. Sales Footprint
19.3.4.5. Strategy Overview
19.3.4.6. SWOT Analysis
19.3.5. Berkeley Advanced Biomaterials
19.3.5.1. Overview
19.3.5.2. Product Portfolio
19.3.5.3. Key Financials by Market Segments (Product/Channel/Region)
19.3.5.4. Sales Footprint
19.3.5.5. Strategy Overview
19.3.5.6. SWOT Analysis
19.3.6. BASF SE
19.3.6.1. Overview
19.3.6.2. Product Portfolio
19.3.6.3. Key Financials by Market Segments (Product/Channel/Region)
19.3.6.4. Sales Footprint
19.3.6.5. Strategy Overview
19.3.6.6. SWOT Analysis
19.3.7. Zimmer Biomet Holdings, Inc.
19.3.7.1. Overview
19.3.7.2. Product Portfolio
19.3.7.3. Key Financials by Market Segments (Product/Channel/Region)
19.3.7.4. Sales Footprint
19.3.7.5. Strategy Overview
19.3.7.6. SWOT Analysis
19.3.8. Stryker
19.3.8.1. Overview
19.3.8.2. Product Portfolio
19.3.8.3. Key Financials by Market Segments (Product/Channel/Region)
19.3.8.4. Sales Footprint
19.3.8.5. Strategy Overview
19.3.8.6. SWOT Analysis
19.3.9. Covalon Technologies Ltd.
19.3.9.1. Overview
19.3.9.2. Product Portfolio
19.3.9.3. Key Financials by Market Segments (Product/Channel/Region)
19.3.9.4. Sales Footprint
19.3.9.5. Strategy Overview
19.3.9.6. SWOT Analysis
19.3.10. Johnson & Johnson
19.3.10.1. Overview
19.3.10.2. Product Portfolio
19.3.10.3. Key Financials by Market Segments (Product/Channel/Region)
19.3.10.4. Sales Footprint
19.3.10.5. Strategy Overview
19.3.10.6. SWOT Analysis
20. Assumptions and Acronyms Used
21. Research Methodology
Table 01: Global Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By MaterialTable 02: Global Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Application
Table 03: Global Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Region
Table 04: North America Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Country
Table 05: North America Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Material
Table 06: North America Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Application
Table 07: Latin America Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Country
Table 08: Latin America Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Material
Table 09: Latin America Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Application
Table 10: Europe Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Country
Table 11: Europe Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Material
Table 12: Europe Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Application
Table 13: East Asia Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Country
Table 14: East Asia Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Material
Table 15: East Asia Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Application
Table 16: South Asia Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Country
Table 17: South Asia Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Material
Table 18: South Asia Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Application
Table 19: Oceania Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Country
Table 20: Oceania Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Material
Table 21: Oceania Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Application
Table 22: Middle East and Africa (MEA) Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Country
Table 23: Middle East and Africa (MEA) Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Material
Table 24: Middle East and Africa (MEA) Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Application